Bitlock Wallet Confirms Mobile App Launch, Bringing Its All-in-One Crypto Platform to iOS and Android 
Sri Lanka and the Middle East’s top real estate achievements recognised at 2025 PropertyGuru Asia Property Awards 
Winmar Holdings Announces Strategic Partnership with CNAE Power for Renewable Energy Storage 
Winmar Holdings Announces Strategic Partnership with CNAE Power for Renewable Energy Storage 
Filmio Studios Unveils New Fan-Commitment Data Layer as Superfan Beta Reveals Early Greenlighting Signals R2 Recycling Is Taking The Right Steps For Proper IT Asset Management
LAKEWOOD, NJ / ACCESSWIRE / June 4, 2021 / Over the span of less than…
T Stamp Inc Announces Successful Completion of a Private Offering
US $4 million raised from new and existing Shareholders in private fundraise ATLANTA, GA /…
Avnio Launches New Solution Enabling Businesses to Supercharge Salesforce Data
London-based software company Avnio, unveils Tables to help organisations increase productivity, drive insights and create…
Pharvaris Presents Pharmacokinetic and Pharmacodynamic Data for Oral PHA121, Under Development for the Treatment of HAE, at 12th C1 Inhibitor Deficiency and Angioedema Workshop
ZUG, Switzerland, June 04, 2021 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company focused…
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Mechelen, Belgium; 4 June 2021; 07.01 CET; – Galapagos NV (Euronext & Nasdaq: GLPG) today…
Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for…
Coherus and Junshi Biosciences Announce Toripalimab in Combination with Chemotherapy Met Primary Progression Free Survival (PFS) Endpoint as First Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
– In pivotal Phase 3 JUPITER-02 study, toripalimab plus chemotherapy significantly improved PFS compared to…
Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera
At final analysis, study showed clinically relevant improvement in median overall survival with a difference…
Coherus and Junshi Biosciences Announce Toripalimab in Combination with Chemotherapy Met Primary Progression Free Survival (PFS) Endpoint as First Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
– In pivotal Phase 3 JUPITER-02 study, toripalimab plus chemotherapy significantly improved PFS compared to…
ECMOHO Limited Announces First Quarter 2021 Unaudited Financial Results
SHANGHAI, China, June 04, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the…
New Phase 3 Data at WCPGHAN Show Long-Term Safety, Tolerability, and Treatment Benefits of Bylvay™ (odevixibat) in PFIC
– Data being presented show long-term benefits of Bylvay in children with PFIC – –…
Vincerx Pharma Announces First Patient Dosed in Phase 1b Study of VIP152 in MYC-Driven Relapsed or Refractory Aggressive Lymphomas and Advanced Solid Tumors
First patient dosed by Vincerx marks significant milestone in Company’s development PALO ALTO, Calif., June…
Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
Company announcement – No. 36/ 2021 Zealand Pharma to Participate in Goldman Sachs 42nd Annual…
Bioasis Announces Publication Validating its xB³ ™ Platform Technology for CNS Therapeutics
NEW HAVEN, Conn., June 03, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
Timber Pharmaceuticals Announces Adjournment of Annual Meeting
Basking Ridge, NJ, June 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc….
Evelo Biosciences Announces Inducement Award Plan for Expanding Leadership Team
CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical…
Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Syndrome
DUBLIN, Ireland and TREVOSE, Pa., June 03, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq:…
Catalyst Pharmaceuticals, Inc.’s and KYE Pharmaceuticals’ Lawsuit in Canadian Federal Court Quashes the Notice of Compliance (NOC) for Ruzurgi®
– Without an NOC, Ruzurgi® is without a Marketing Authorization in Canada – Matter Remanded…
Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate
Saint-Herblain (France), June 3, 2021 –Valneva SE, a specialty vaccine company focused on the development…
Novartis 177Lu-PSMA-617 significantly improves overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer in Phase III VISION study
Men who received 177Lu-PSMA-617 plus best standard of care had a 38% reduction in risk…